Tempus AI (NASDAQ:TEM) Stock Price Up 3.1% – Time to Buy?

Shares of Tempus AI, Inc. (NASDAQ:TEM) were up 3.1% during trading on Tuesday . The company traded as high as $68.81 and last traded at $67.70. Approximately 3,230,482 shares were traded during trading, a decline of 54% from the average daily volume of 7,093,864 shares. The stock had previously closed at $65.65.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. BTIG Research began coverage on shares of Tempus AI in a research note on Monday, April 21st. They set a “buy” rating and a $60.00 price target on the stock. Piper Sandler raised their target price on Tempus AI from $55.00 to $70.00 and gave the stock a “neutral” rating in a report on Thursday, May 15th. Bank of America boosted their price target on Tempus AI from $48.00 to $68.00 and gave the company a “neutral” rating in a report on Tuesday, May 20th. Morgan Stanley upped their price target on Tempus AI from $60.00 to $65.00 and gave the stock an “overweight” rating in a research report on Friday, May 9th. Finally, Guggenheim reaffirmed a “buy” rating on shares of Tempus AI in a research report on Tuesday, February 25th. Six equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $63.42.

Tempus AI Price Performance

The company has a quick ratio of 1.56, a current ratio of 1.71 and a debt-to-equity ratio of 2.45. The firm’s fifty day moving average price is $59.18 and its 200 day moving average price is $52.81. The stock has a market cap of $11.40 billion and a PE ratio of -8.45.

Tempus AI (NASDAQ:TEM) last announced its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) EPS for the quarter, topping the consensus estimate of ($0.27) by $0.03. The business had revenue of $255.74 million for the quarter, compared to analysts’ expectations of $248.13 million. Tempus AI had a negative net margin of 88.27% and a negative return on equity of 533.21%. The business’s revenue was up 75.4% on a year-over-year basis. As a group, equities analysts expect that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Insider Buying and Selling at Tempus AI

In other news, CAO Ryan M. Bartolucci sold 6,073 shares of Tempus AI stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $63.23, for a total value of $383,995.79. Following the completion of the transaction, the chief accounting officer now owns 47,799 shares in the company, valued at approximately $3,022,330.77. The trade was a 11.27% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Eric P. Lefkofsky sold 250,000 shares of the business’s stock in a transaction that occurred on Tuesday, June 17th. The shares were sold at an average price of $70.07, for a total value of $17,517,500.00. Following the transaction, the chief executive officer now directly owns 9,357,283 shares in the company, valued at approximately $655,664,819.81. This represents a 2.60% decrease in their position. The disclosure for this sale can be found here. Insiders sold 609,897 shares of company stock worth $41,397,783 in the last quarter. 27.60% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of TEM. Operose Advisors LLC bought a new stake in shares of Tempus AI in the 4th quarter worth about $25,000. Cherry Tree Wealth Management LLC purchased a new position in shares of Tempus AI during the first quarter valued at approximately $31,000. University of Texas Texas AM Investment Management Co. bought a new position in shares of Tempus AI during the first quarter valued at approximately $33,000. Farther Finance Advisors LLC bought a new position in shares of Tempus AI during the fourth quarter valued at approximately $34,000. Finally, Prestige Wealth Management Group LLC raised its holdings in shares of Tempus AI by 910.4% in the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock worth $36,000 after buying an additional 965 shares during the period. Institutional investors own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.